Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Lamb who wrote (292)	6/12/1998 12:24:00 AM
From: Anthony Wong	Respond to of 1722

Thanks again, Jim. Deadlines for articles in magazines like Playboy, Penthouse etc. are usually fixed several months ahead of the published date (not so for news-type magazines like Newsweek and Time). If I were the editor, I would ditch a pre-arranged cover and put Viagra on it as soon as possible. I know Hugh is using Viagra, and he's been quoted many times on this subject.

To: Jim Lamb who wrote (292)	6/12/1998 12:33:00 AM
From: Anthony Wong	Respond to of 1722

Viagra sales disappoint in Mexico Thursday June 11, 11:11 pm Eastern Time biz.yahoo.com

To: Jim Lamb who wrote (292)	6/12/1998 12:34:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

Viagra hits Greek black market Thursday June 11 9:47 PM EDT ATHENS, Greece, June 11 (UPI) - Viagra, the world's wonder drug for male impotence, has made its way to Greece, stimulating the country's black market pharmaceutical industry. An Athens daily newspaper today quoted experts at the Greek Institute for Male Sexuality as saying Viagra is being distributed secretly, even though the European Union has not given it the official stamp of approval. The institute's president, D.L Kontogiorgos, said: ''The drug has found its way to Greece as well. Unfortunately it is being sold in an unregulated fashion to a number of people who are ill-informed at best.'' News of Viagra has stirred Greeks into a frenzy while the country's scientific community remains split as to its side effects, including headaches, hot flashes and urinary tract infections. Greek health officials expect the drug to be approved by the end of the year. Copyright 1998 by United Press International. All rights reserved. dailynews.yahoo.com